A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies.
about
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemiaNovel therapy for childhood acute lymphoblastic leukemia.Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience.Rituximab in the management of acute lymphoblastic leukemia.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma.Combination therapy with the type II anti-CD20 antibody obinutuzumab.Modulation of IgG1 immunoeffector function by glycoengineering of the GDP-fucose biosynthesis pathway.
P2860
Q38640263-9A40E65A-B2D2-4C37-B8BE-1FE0624DA2B0Q39368957-88EDB5AE-18C0-4D51-B1EE-D66484461F87Q46675870-4A171BF5-6F22-4DE2-B279-18CBBCC9C69BQ47196522-5FA419E1-BDD8-4F36-ADA5-75B25AB6526FQ47221234-A55020AB-1233-4F39-AF25-B70B5C55A99BQ47563526-A0E6AD64-7D25-4C53-BE75-60A23CBAB2BEQ47898168-5F0C49A7-DF11-4D48-A0B4-56D146B7D073Q48278134-C8D2EE1B-226A-4B75-8E9B-D989215C985B
P2860
A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Review of Obinutuzumab (GA10 ...... ents with B-Cell Malignancies.
@en
A Review of Obinutuzumab (GA10 ...... ents with B-Cell Malignancies.
@nl
type
label
A Review of Obinutuzumab (GA10 ...... ents with B-Cell Malignancies.
@en
A Review of Obinutuzumab (GA10 ...... ents with B-Cell Malignancies.
@nl
prefLabel
A Review of Obinutuzumab (GA10 ...... ents with B-Cell Malignancies.
@en
A Review of Obinutuzumab (GA10 ...... ents with B-Cell Malignancies.
@nl
P2093
P2860
P921
P1433
P1476
A Review of Obinutuzumab (GA10 ...... ents with B-Cell Malignancies.
@en
P2093
Christian Klein
Günter Fingerle-Rowson
Kensei Tobinai
P2860
P2888
P304
P356
10.1007/S12325-016-0451-1
P407
P577
2016-12-21T00:00:00Z
2017-02-01T00:00:00Z